Early Results Indicate Stockholders Are Approving SCPIE Holdings Merger Agreement with The Doctors Company

  
    
  
  
    
      SCPIE Holdings Inc. (NYSE:SKP), a major provider of healthcare 
      liability insurance, today announced that based on unofficial early 
      results, significantly more than the 50% of outstanding shares necessary 
      for approval were voted FOR the adoption of the merger agreement with 
      The Doctors Company, a leading physician-owned medical malpractice 
      carrier. The merger agreement provides for the purchase of SCPIE for 
      $28.00 per share in cash, or an aggregate purchase price of 
      approximately $281 million. In addition to approval by SCPIE’s 
      stockholders, the transaction is subject to the receipt of insurance 
      regulatory approvals. The final vote count by the independent inspectors 
      of election, IVS Associates Inc., is expected within two weeks.
    
    
      Forward-Looking Statements
    
    
      In addition to historical information, this news release contains 
      forward-looking statements that are based upon the Company’s 
      estimates and expectations concerning future events and are subject to 
      certain risks and uncertainties that could cause actual results to 
      differ materially from those reflected in the forward-looking statements. 
      Risks and uncertainties regarding the pending transaction with The 
      Doctors Company include the possibility that the closing does not occur, 
      or is delayed, due to the failure of closing conditions (including 
      approval by the Company’s stockholders and 
      regulatory authorities) and risks that the pending transaction could 
      disrupt current plans and opportunities of the Company. Other factors 
      that may cause actual results to differ from the forward-looking 
      statements contained herein and that may affect the Company’s 
      prospects are included in the Company’s other 
      filings with the Securities and Exchange Commission. In light of the 
      significant uncertainties inherent in the forward-looking information 
      herein, the inclusion of such information should not be regarded as 
      representation by the Company or any other person that the Company’s 
      objectives or plans will be realized.